Loading...


*  Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin - Full Text View - ClinicalTrials.gov
Neoplasms, Unknown Primary. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Neoplasm Metastasis. ... Carcinoma of Unknown Primary Drug: carboplatin Drug: etoposide Drug: fluorouracil Drug: leucovorin calcium Drug: paclitaxel ... Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin. The safety and scientific validity of this study is ... It is not yet known which combination chemotherapy regimen is more effective for cancer of unknown primary origin. ...
  https://clinicaltrials.gov/ct2/show/NCT00003558
*  Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site - Full Text View -...
Neoplasms, Unknown Primary. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Neoplasm Metastasis. ... Carcinoma of Unknown Primary Drug: Carboplatin Drug: Gemcitabine Drug: Capecitabine Phase 2 ... Currently, carcinoma of unknown primary site (CUP) accounts for about 5% of all newly diagnosed malignancies. The stage of the ... This study is for patients with a type of cancer called carcinoma of unknown primary site (CUP), meaning that the site of the ...
  https://clinicaltrials.gov/ct2/show/NCT00148135
*  Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site - Full Text View -...
Neoplasms, Unknown Primary. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Neoplasm Metastasis. ... Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site. The safety and ... Carcinoma of Unknown Primary Drug: Carboplatin Drug: Gemcitabine Drug: Capecitabine Phase 2 ... Currently, carcinoma of unknown primary site (CUP) accounts for about 5% of all newly diagnosed malignancies. The stage of the ...
  https://clinicaltrials.gov/show/NCT00148135
*  Pathobiology of diffuse large B cell lymphoma and primary mediastinal large B cell lymphoma
See 'Classification of the hematopoietic neoplasms'.). The molecular pathogenesis of DLBCL is a complex, multistep process that ... While some steps in this pathway have been elucidated, many remain unknown. The best-characterized oncogenic events are ... Primary diffuse large B cell lymphoma of the mediastinum, also called primary mediastinal large B cell lymphoma. (See 'Primary ... Pathobiology of diffuse large B cell lymphoma and primary mediastinal large B cell lymphoma. Authors. Jennifer R Brown, MD, PhD ...
  https://www.uptodate.com/contents/pathobiology-of-diffuse-large-b-cell-lymphoma-and-primary-mediastinal-large-b-cell-lymphoma
*  Seminars in Diagnostic Pathology | ScienceDirect.com
Diagnosis and management of metastatic neoplasms with unknown primary. Review article. In Press, Corrected Proof, Available ... Immunohistochemistry, carcinomas of unknown primary, and incidence rates. Review article. In Press, Corrected Proof, Available ... Metastases of malignant neoplasms: Historical, biological, & clinical considerations. Review article. In Press, Corrected Proof ...
  http://www.sciencedirect.com/journal/seminars-in-diagnostic-pathology
*  Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to...
Neoplasms, Unknown Primary. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Neoplasms, Squamous ... Neoplasms by Site. Mouth Neoplasms. Mouth Diseases. Stomatognathic Diseases. Salivary Gland Diseases. Neoplasm Metastasis. ... PRIMARY OBJECTIVES:. I. Primary endpoint is progression free survival (PFS) of cetuximab/temsirolimus combination cohort (Arm A ... Primary Completion Date:. December 2013 (Final data collection date for primary outcome measure). ...
  https://clinicaltrials.gov/ct2/show/NCT01256385?term=sirolimus+cancer&recr=Open&rank=14
*  Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer - Full Text View - ClinicalTrials.gov
Neoplasms, Unknown Primary. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Neoplasms by Site. ... Carcinoma of Unknown Primary Head and Neck Cancer Drug: mitomycin C Drug: porfiromycin Radiation: brachytherapy Radiation: ... Primary Completion Date:. October 2002 (Final data collection date for primary outcome measure). ... Hypopharynx Oral cavity Larynx Oropharynx Nasopharynx Unknown primary origin with positive head and neck nodes TNM Stages I-IV ...
  https://clinicaltrials.gov/show/NCT00002507
*  CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma - Full Text View ...
Uveal Neoplasms. Carcinoma. Neoplasms, Unknown Primary. Neuroendocrine Tumors. Neuroectodermal Tumors. Neoplasms, Germ Cell and ... Neoplasms by Histologic Type. Neoplasms. Neoplasms, Nerve Tissue. Nevi and Melanomas. Eye Neoplasms. Neoplasms by Site. Eye ... Patients may have had primary cutaneous, mucosal, or ocular melanoma or metastasis from an unknown primary site ... Carcinoma of Unknown Primary Origin Iris Melanoma Medium/Large Size Posterior Uveal Melanoma Mucosal Melanoma Ocular Melanoma ...
  https://clinicaltrials.gov/ct2/show/NCT02129075
*  Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary - Full...
Neoplasms, Unknown Primary. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasm Metastasis. ... Tumors Unknown Primary Tumors Adenocarcinoma Drug: Capecitabine Drug: Carboplatin Drug: Paclitaxel Phase 1 Phase 2 ... Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary. This ... Primary Completion Date:. November 2007 (Final data collection date for primary outcome measure). ...
  https://clinicaltrials.gov/show/NCT00201734
*  Phase III Randomized, Placebo Controlled, Trial Of Docetaxel Versus Docetaxel Plus ZD1839 (Iressa, Gefitinib, NSC 715055) In...
Neoplasms, Unknown Primary. *Salivary Gland Neoplasms. *Hypopharyngeal Neoplasms. *Laryngeal Neoplasms. *Paranasal Sinus ... PRIMARY OBJECTIVES:. I. To determine the survival of poor prognosis patients with recurrent/metastatic squamous. cell carcinoma ... on the developing human fetus are unknown. - All females of childbearing potential must have a blood test or urine study within ... chemotherapy as part of potentially curative therapy of primary disease. within 6 months of randomization will be considered as ...
  http://www.knowcancer.com/cancer-trials/NCT00088907/
*  Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is...
Neoplasms, Unknown Primary. *Salivary Gland Neoplasms. *Hypopharyngeal Neoplasms. *Laryngeal Neoplasms. *Paranasal Sinus ... Metastatic Squamous Neck Cancer With Occult Primary. *Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell ... Metastatic Squamous Neck Cancer With Occult Primary, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell ... PRIMARY OBJECTIVES:. I. To find a safe and tolerable interleukin (IL)-12 (recombinant interleukin-12) dose for. use in ...
  http://www.knowcancer.com/cancer-trials/NCT01468896/
*  Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor
Unknown Primary Tumors. *Neoplasms, Unknown Primary. .map{width:100%;height:300px;margin-bottom:15px;} Name. Location. ... 1. Unknown primary tumors. 2. ECOG performance status 0-1. 3. Adequate kidney, liver and bone marrow function. 4. No prior ... Gemcitabine and Avastin in Patients With Unknown Primary Tumors. Trial Phase:. Phase 2. Minimum Age:. 18 Years. Maximum Age:. ... Gemcitabine and Avastin in Patients With Unknown Primary Tumors. Upon determination of eligibility, all patients will be ...
  http://www.knowcancer.com/cancer-trials/NCT00458315/
*  Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck...
Head and Neck Neoplasms. *Neoplasms, Unknown Primary. *Salivary Gland Neoplasms. *Hypopharyngeal Neoplasms ... PRIMARY OBJECTIVES:. I. Examine disease-free survival (DFS) given afatinib/placebo adjuvant therapy in patients. with viable ... tumor cells following primary concurrent chemoradiotherapy of locoregionally advanced. (stage III/IV) head and neck squamous ... Patients must have achieved a complete response at the primary disease site after. chemoradiotherapy. - All persistent lymph ...
  http://www.knowcancer.com/cancer-trials/NCT01824823/
*  Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
Neoplasm, Unknown Primary. *Neoplasm, Unknown Primary. *Neoplasms. *Carcinoma. *Neoplasms, Unknown Primary. .map{width:100%; ... of Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Patients With Carcinoma of Unknown Primary ... of Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Patients With Carcinoma of Unknown Primary ...
  http://www.knowcancer.com/cancer-trials/NCT00360360/
*  Gemox as First and Second Line Therapy in Unknown Primary Cancer
Primary objectives:1. To determine the overall tumor response rate with oxaliplatin in combination with gemcitabine (GEMOX) as ... Unknown Primary Neoplasms. *Unknown Primary Neoplasms. *UPC. *Unknown Primary Cancer. *Questionnaire. *Gemcitabine ... with unknown primaries is still considered investigational. Up to 81 people will take part. in this study. All will be enrolled ... unknown primary cancer. If the patients are previously treated, they may not have had. previous exposure to gemcitabine or ...
  http://www.knowcancer.com/cancer-trials/NCT00353145/
*  Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors - Full Text View -...
Neoplasms. Meningitis. Nervous System Neoplasms. Central Nervous System Neoplasms. Carcinoma. Neoplasms, Unknown Primary. ... Neoplasms by Site. Neoplasms, Glandular and Epithelial. Neoplasm Metastasis. Neoplastic Processes. Pathologic Processes. ... including primary CNS tumors or carcinomas of unknown primary site), defined by 1 of the following criteria:. *Cerebral spinal ... Brain and Central Nervous System Tumors Carcinoma of Unknown Primary Leukemia Lymphoma Unspecified Childhood Solid Tumor, ...
  https://clinicaltrials.gov/show/NCT00112619?order=129
*  basal cell carcinoma of external ear 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Ear Neoplasms / secondary. Head and Neck Neoplasms / secondary. Neoplasms, Unknown Primary / pathology. Skin Neoplasms / ... Ear Neoplasms / radiotherapy. Ear, External. Eyelid Neoplasms / radiotherapy. Nose Neoplasms / radiotherapy. Skin Neoplasms / ... MeSH-major] Ear Neoplasms / pathology. Ear Neoplasms / surgery. Mohs Surgery. Skin Neoplasms / pathology. Skin Neoplasms / ... Neoplasm Invasiveness. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Neoplasm Staging. Parotid ...
  http://www.bmlsearch.com/?kwr=basal+cell+carcinoma+of+external+ear+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
*  adenocarcinoma in situ of thyroid 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Neoplasms, Unknown Primary / diagnosis. *[MeSH-minor] Biopsy. Diagnosis, Differential. Humans. Immunohistochemistry. In Situ ... Lung Neoplasms / metabolism. Lung Neoplasms / pathology. Lung Neoplasms / secondary. Lung Neoplasms / surgery. Neoplasm ... Neoplasms, Multiple Primary / genetics. Ovarian Neoplasms / genetics. Struma Ovarii / genetics. Thyroid Neoplasms / genetics. ... Kidney Neoplasms / epidemiology. Melanoma / epidemiology. Neoplasms, Second Primary / epidemiology. Thyroid Neoplasms / ...
  http://www.bmlsearch.com/?kwr=adenocarcinoma+in+situ+of+thyroid+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
*  Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer
Central Nervous System Neoplasms. *Neoplasms, Germ Cell and Embryonal. *Neoplasms, Unknown Primary ... Responsive bladder, head and neck carcinoma, or carcinoma of unknown primary Other tumors. without curative or first line ... Bladder Cancer, Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary, Extragonadal Germ Cell Tumor, Head and ...
  http://www.knowcancer.com/cancer-trials/NCT00003657/
*  Case 138 --Neuropathology Case
Final clinical report suggested a metastatic neoplasm with unknown primary.. NEUROIMAGING:. Until October 2003, no significant ... primary tumor like renal cell cancer or melanoma) or a systemic lymphatic disease.. GROSS AND MICROSCOPIC PATHOLOGY:. The ...
  https://path.upmc.edu/divisions/neuropath/bpath/cases/case138.html
*  neoplasm of muscle of neck drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Head and Neck Neoplasms / secondary. Lymphatic Metastasis / pathology. Neck Dissection. Neoplasms, Unknown Primary / surgery ... Neoplasm, Residual / diagnosis. Neoplasm, Residual / drug therapy. Neoplasm, Residual / radiotherapy. Neoplasm, Residual / ... MeSH-major] Soft Tissue Neoplasms / epidemiology. *[MeSH-minor] Humans. Neoplasm Recurrence, Local. Neoplasm Staging. Nigeria ... Colorectal Neoplasms / drug therapy. Head and Neck Neoplasms / drug therapy. Lung Neoplasms / drug therapy. Motor Neuron ...
  http://www.bmlsearch.com/?kwr=neoplasm+of+muscle+of+neck+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
*  Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell...
Salivary Gland Neoplasms. Mouth Neoplasms. Head and Neck Neoplasms. Neoplasms, Unknown Primary. Neoplasms, Glandular and ... Neoplasms by Histologic Type. Neoplasms. Neoplasms, Squamous Cell. Neoplasms by Site. Mouth Diseases. Neoplasm Metastasis. ... from any primary site, including unknown primary cancers of the head and neck; patient must not have nasopharyngeal carcinoma ... Estimated Primary Completion Date :. February 28, 2018. Resource links provided by the National Library of Medicine Genetics ...
  https://www.clinicaltrials.gov/ct2/show/NCT00588770?term=Oral+Cancer&fund=0&rank=49